Clinical Protocol for a Phase II Open-label, Multicenter Long-term Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)
Administered By
Awarded By
Contributors
- Smith, Edward Clinton Principal Investigator
Start/End
- January 20, 2017 - December 31, 2020